Lorcaserin Hydrochloride and Pasireotide Extended-Release Injection
Determining the interaction of Lorcaserin Hydrochloride and Pasireotide Extended-Release Injection and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lorcaserin
Brand name: Belviq, Belviq XR
Synonyms: Lorcaserin
Generic Name: pasireotide
Brand name: Signifor, Signifor LAR
Synonyms: Pasireotide
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lorcaserin Hydrochloride-Pasireotide Injection
- Lorcaserin Hydrochloride-Pasireotide Subcutaneous
- Lorcaserin Hydrochloride-Patanase
- Lorcaserin Hydrochloride-Patiromer
- Lorcaserin Hydrochloride-Patiromer Sorbitex Calcium
- Lorcaserin Hydrochloride-Pavacot
- Pasireotide Extended-Release Injection-Lorcaserin Tablets
- Pasireotide Extended-Release Injection-Lorcet
- Pasireotide Extended-Release Injection-Lorcet Plus
- Pasireotide Extended-Release Injection-Lorcet Tablets
- Pasireotide Extended-Release Injection-Lorlatinib
- Pasireotide Extended-Release Injection-Lortab